Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001641 · ClinicalTrials.gov registry record
Study of Heritable Connective Tissue Disorders
A clinical trial of Ehlers-Danlos Syndrome and Marfan Syndrome, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 900
- Enrollment target
- 1
- Study location
NCT00001641 is a study of Ehlers-Danlos Syndrome and Marfan Syndrome that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 900 participants, above the 392-participant average among 5 other Ehlers-Danlos Syndrome trials with a reported enrollment target (130% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00001641, a study of Ehlers-Danlos Syndrome and Marfan Syndrome, has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are to identify the genes responsible for inherited connective tissue disorders and learn about the range of medical problems they cause. It will investigate whether specific gene changes cause specific medical problems and will establish diagnostic criteria (signs and symptoms) for the individual syndromes. Children and adults with a known or suspected inherited connective tissue disorder (Marfan, Ehlers-Danlos or Stickler syndrome, or other closely related disorders) and their family members may be eligible for this study. Patients enrolled in the study will have a medical history, physical examination and blood tests, as well as other procedures that may include: * Echocardiogram (ultrasound of the heart) * X-rays and other imaging studies, such as magnetic resonance imaging (MRI) or computerized tomography (CT) scans * Lung function studies * Urine tests * Skin biopsy (removal of a small piece of tissue, under local anesthetic, for microscopic examination) * Examination by various specialists (e.g., in ophthalmology, gastroenterology, rehabilitation medicine) as needed * Questionnaires regarding chronic pain and fatigue, quality of life, and the impact of the connective tissue disorder on the patient and family. (Patients who wish to enroll but cannot travel to NIH may have a more limited participation, including review of medical records, telephone interview regarding personal and family history, and collection of a specimen (blood, skin biopsy, or other) for genetic testing. Patients will be notified of genetic testing results that show a change responsible for their connective tissue disorder. If they wish, the information will also be sent to their local health care provider, along with recommendations for additional tests or treatment options. No treatment is offered as part of this study. Participating family members who do not themselves have a connective tissue disorder will provide a small blood sample for gene testing a
Conditions Studied
Study Locations (1)
Maryland
- National Human Genome Research Institute (NHGRI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 1997-03 |
| Est. Completion | 2002-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001641
The ClinicalTrials.gov registry entry for NCT00001641 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 392-participant average among 5 other Ehlers-Danlos Syndrome trials with a reported enrollment target (130% higher). The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Ehlers-Danlos Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00001641 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001641 about?
NCT00001641 is a clinical study titled "Study of Heritable Connective Tissue Disorders". The purposes of this study are to identify the genes responsible for inherited connective tissue disorders and learn about the range of medical problems they cause. It will investigate whether specific gene changes cause specific medical problems and will establish diagnostic criteria (signs and sym...
What is the current status of trial NCT00001641?
This trial is currently completed. The enrollment target is 900 participants. The study started on 1997-03. Estimated completion is 2002-06.
What conditions does trial NCT00001641 study?
This clinical trial studies the following conditions: Ehlers-Danlos Syndrome, Marfan Syndrome, Connective Tissue Disease, Dissecting Aneurysm, Nail Patella Syndrome.
Who is sponsoring clinical trial NCT00001641?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001641 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ehlers-Danlos Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
RECRUITING · NA
-
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
RECRUITING
-
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
RECRUITING · NA
-
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
ACTIVE NOT RECRUITING
-
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.